New Venture Formation: Strategic Decisions

The Office of Technology Commercialization


Invention 2 Innovation (I2I)

“New Venture Formation: Strategic Decisions”

Thursday, November 19, 2015
Leavey Program Room at the Leavey Center
(across from the bookstore)

Have you ever wondered:

Presented by:

Michael Christini, Esq.
CEO and Founder
Catherex, Inc.

Catherex is a clinical stage oncology company developing oncolytic HSV for treatment of glioblastoma and other indications.  As a founder of Catherex, Michael has been involved in all aspects of formation, intellectual property licensing, fundraising and product development.  Michael attended Case Western Reserve University Law School and St. Bonaventure University.

Lunch is provided and space is limited
Please RSVP by Tuesday, November 17, 2015
to Jeremy S. Alexander at jsa [at] georgetown [dot] edu or 202.687.7424.

Faculty, entrepreneurs, fellows, students, and research administrators should attend.